13.63
13.63 (0.62%)
As of Mar 06, 2024
Liquidia Corp [LQDA]
Source:
Company Overview
We are a biopharmaceutical company focused on the development, manufacturing and commercialization of products that address unmet patient needs, with current focus directed towards the treatment of pulmonary hypertension (PH). We operate as a single entity through our two wholly owned operating subsidiaries, Liquidia Technologies and Liquidia PAH (formerly known as RareGen).
Country | United States |
Headquarters | morrisville, north carolina |
Phone Number | 919.328.4400 |
Industry | |
CEO | Roger A. Jeffs |
Website |